Medicalg (WAR:MDG) — Stock Price
Medicalg (WAR:MDG) is currently trading at zł26.90 PLN, down 2.00% today. Over the past 52 weeks, shares have ranged between zł24.50 and zł42.60. This page tracks Medicalg's live share price on the WAR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Medicalg.
Medicalg (MDG) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Medicalg's daily closing share price and trading volume on the WAR exchange over the past year, giving a clear view of recent price momentum and liquidity.
Medicalg Income Statement — Revenue, Profit & Earnings by Year
Medicalg's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | zł30.98 Million | zł24.00 Million | zł43.10 Million | zł62.72 Million | zł48.35 Million |
| Cost of Revenue | zł3.65 Million | zł3.63 Million | zł26.14 Million | zł12.35 Million | zł7.39 Million |
| Gross Profit | zł27.34 Million | zł20.37 Million | zł16.95 Million | zł50.37 Million | zł113.17 Million |
| Research & Development | — | — | zł936.00K | zł2.59 Million | zł2.59 Million |
| SG&A | zł3.46 Million | zł3.76 Million | zł13.35 Million | zł5.02 Million | zł31.07 Million |
| Total Operating Expenses | zł39.12 Million | zł36.91 Million | zł16.52 Million | zł7.54 Million | zł117.57 Million |
| Operating Income | zł-8.13 Million | zł-16.54 Million | zł433.00K | zł17.21 Million | zł-4.40 Million |
| EBITDA | — | zł-11.98 Million | zł2.23 Million | zł29.75 Million | zł-2.20 Million |
| EBIT | — | zł-15.61 Million | zł-130.00K | zł25.53 Million | zł-6.39 Million |
| Interest Expense | zł2.04 Million | zł163.00K | zł108.00K | zł271.00K | zł620.00K |
| Income Before Tax | zł-11.70 Million | zł-15.78 Million | zł-238.00K | zł25.26 Million | zł-7.01 Million |
| Income Tax Expense | — | zł302.00K | zł340.00K | zł-216.00K | zł438.00K |
| Net Income | zł-11.68 Million | zł-16.08 Million | zł-578.00K | zł-11.86 Million | zł-180.64 Million |
Medicalg Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Medicalg's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | zł108.23 Million | zł105.81 Million | zł121.63 Million | zł108.74 Million | zł114.41 Million |
| Total Current Assets | zł16.85 Million | zł22.37 Million | zł43.23 Million | zł56.08 Million | zł36.75 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | zł8.67 Million | zł7.47 Million | zł8.40 Million | zł21.00 Million | zł23.19 Million |
| Inventory | zł5.45 Million | zł9.39 Million | zł9.32 Million | zł8.77 Million | zł0.00 |
| Property, Plant & Equipment | — | — | — | zł2.00 Million | zł27.00 Million |
| Goodwill | zł18.97 Million | zł18.97 Million | zł18.97 Million | zł18.97 Million | zł766.00K |
| Total Liabilities | zł43.59 Million | zł28.63 Million | zł29.07 Million | zł28.66 Million | zł67.02 Million |
| Total Current Liabilities | zł12.99 Million | zł8.97 Million | zł12.29 Million | zł10.28 Million | zł40.26 Million |
| Long-term Debt | zł17.22 Million | zł2.65 Million | zł0.00 | zł0.00 | zł8.12 Million |
| Net Debt | zł16.16 Million | zł-1.37 Million | zł-19.81 Million | zł-26.16 Million | zł-2.02 Million |
| Total Stockholder Equity | zł64.62 Million | zł77.17 Million | zł92.56 Million | zł94.67 Million | zł47.38 Million |
| Retained Earnings | zł-145.14 Million | zł-133.46 Million | zł-117.38 Million | zł-116.80 Million | zł-104.76 Million |
Medicalg Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Medicalg generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | zł-1.82 Million | zł-13.08 Million | zł182.00K | zł6.33 Million | zł-6.48 Million |
| Capital Expenditures | zł13.79 Million | zł9.97 Million | zł11.32 Million | zł12.37 Million | zł15.88 Million |
| Free Cash Flow | zł-15.61 Million | zł-23.05 Million | zł-11.14 Million | zł-6.04 Million | zł-22.36 Million |
| Investing Cash Flow | — | zł-7.37 Million | zł1.96 Million | zł-1.81 Million | zł-15.78 Million |
| Financing Cash Flow | — | zł447.00K | zł-2.81 Million | zł9.98 Million | zł17.73 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | zł297.00K | zł423.00K | zł0.00 | — | — |
| Depreciation | zł4.64 Million | zł3.63 Million | zł2.37 Million | zł4.22 Million | zł17.53 Million |
| Change in Cash | zł-2.78 Million | zł-20.00 Million | zł-664.00K | zł14.50 Million | zł-4.53 Million |
Medicalg Earnings History — EPS Actual vs. Analyst Estimates
Track Medicalg's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2026 | -0.22 | — | — |
| Dec 31, 2025 | -0.09 | — | — |
| Sep 30, 2025 | -0.41 | — | — |
| Jun 30, 2025 | -0.25 | — | — |
| Mar 31, 2025 | -0.42 | — | — |
| Dec 31, 2024 | -0.47 | — | — |
| Nov 29, 2024 | -0.21 | — | — |
| Sep 30, 2024 | -0.53 | — | — |